comparemela.com

Latest Breaking News On - Sonia benhamida - Page 1 : comparemela.com

Nicox's Ordinary and Extraordinary Shareholders' Meeting on

Press Release Nicox’s Ordinary and Extraordinary Shareholders Meeting on May 6, 2024 Shareholders adopted all resolutions proposed by the Board of.

Antibes
Provence-alpes-côd-azur
France
New-york
United-states
Paris
France-general
Biot
China
Blackrock
Chinese
Sonia-benhamida

Crescendo widens pivotal solid tumour therapy trial

Crescendo widens pivotal solid tumour therapy trial
pharmatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmatimes.com Daily Mail and Mail on Sunday newspapers.

Sonia-benhamida
Theodora-harold
Ip-group-biontech
Andera-partners
Sofinnova-partners
Quan-capital
Kreos-capital
Crescendo-biologics

Crescendo Biologics secures $32M and announces expansion of CB307 Phase 1b trial in PSMA+ solid tumours

Crescendo Biologics secures $32M and announces expansion of CB307 Phase 1b trial in PSMA+ solid tumours
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

United-kingdom
Cambridge
Cambridgeshire
Theodora-harold
Sonia-benhamida
Crescendo-biologics-ltd
Ip-group-biontech
Linkedin
Ip-group
Zai-lab
Kreos-capital
Biologics-ltd

IP : Crescendo Biologics - Secures $32M and announces expansion of CB307 Phase 1b trial in PSMA+ solid tumours

24 Jul 2023 $32 million additional capital raised, supported by all major existing investors and new investor Kreos Capital .

United-kingdom
Cambridge
Cambridgeshire
Theodora-harold
Melanie-toyne-sewell-adam-loudon
Sonia-benhamida
Crescendo-biologics-ltd
Zai-lab
Ip-group-biontech
Ip-group
Kreos-capital
Biologics-ltd

vimarsana © 2020. All Rights Reserved.